Original Biomedicals Co (ROCO:6483) Net Margin %: 0.00% (As of Dec. 2025)


ROCO:6483 Original Biomedicals Co Ltd ROCO:6483
32 GF Score
Price NT$13.40
! 2 Warning Signs
View Full Analysis

What is Original Biomedicals Co Net Margin %?

Original Biomedicals Co ROCO:6483 32 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates ROCO:6483 with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 962 Drug Manufacturers companies, Original Biomedicals Co ranks worse than 99.17% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Original Biomedicals Co's Net Income for the six months ended in Dec. 2025 was NT$-53.91 Mil. Original Biomedicals Co's Revenue for the six months ended in Dec. 2025 was NT$0.00 Mil. Therefore, Original Biomedicals Co's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Original Biomedicals Co's Net Margin % or its related term are showing as below:

ROCO:6483' s Net Margin % Range Over the Past 10 Years
Min: -138746.51   Med: -32142.55   Max: -869.76
Current: -26643.05


ROCO:6483's Net Margin % is ranked worse than
99.17% of 962 companies
in the Drug Manufacturers industry
Industry Median: 5.56 vs ROCO:6483: -26643.05

Original Biomedicals Co  (ROCO:6483) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Original Biomedicals Co Net Margin % Related Terms


Original Biomedicals Co Net Margin % Historical Data

* Premium members only.

The historical data trend for Original Biomedicals Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Original Biomedicals Co Net Margin % Chart

Original Biomedicals Co Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 -37,642.06 -138,746.51 0.00 -26,643.04

Original Biomedicals Co Semi-Annual Data
Dec11 Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -12,492.91 0.00

ROCO:6483 vs ZTS, UTHR: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Original Biomedicals Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Original Biomedicals Co Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Original Biomedicals Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Original Biomedicals Co's Net Margin % falls into.


ROCO:6483
32GF Score
Original Biomedicals Co Ltd ROCO:6483
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Original Biomedicals Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Original Biomedicals Co's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-101.51/0.381
=-26,643.04 %

Original Biomedicals Co's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-53.912/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Original Biomedicals Co (ROCO:6483) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Original Biomedicals Co and its competitors. According to the industry distribution chart, Original Biomedicals Co ranks #954 out of 962 companies in the Drug Manufacturers industry, placing it in the top 99.2%.
Is Original Biomedicals Co's Net Margin % too high?
Original Biomedicals Co's current Net Margin % is 0.00%. Based on the distribution chart, Original Biomedicals Co ranks #954 out of 962 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Original Biomedicals Co has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Original Biomedicals Co's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Original Biomedicals Co ranks #954 out of 962 companies for Net Margin %. This places Original Biomedicals Co in the lower half of its industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Original Biomedicals Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Original Biomedicals Co's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Original Biomedicals Co stock overvalued right now?
Original Biomedicals Co (ROCO:6483) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Original Biomedicals Co's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Original Biomedicals Co (ROCO:6483), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Original Biomedicals Co Business Description

Address No. 9, Nanke 2nd Road, 2 Floor-1, Xinshi District, Tainan, TWN, 74147
Original Biomedicals Co Ltd is a biopharmaceutical company engaged in the research and development of drugs. The company focuses on developing new drug formulations, drug delivery systems, and repurposing existing pharmaceutical products.
32GF Score

Get the complete analysis for ROCO:6483

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.40
Price